Tirzepatide – 5Mg

$55.00

Tirzepatide is a novel dual-action peptide that functions as both a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. As the first of its class to target both incretin receptors simultaneously, Tirzepatide has demonstrated remarkable results in research settings related to metabolic health, insulin sensitivity, and body weight reduction. Its dual-receptor mechanism allows it to amplify the effects seen with GLP-1 agonists alone, producing a more pronounced response in appetite regulation, glucose control, and fat metabolism. Comprised of 39 amino acids with a fatty acid modification for extended half-life, Tirzepatide is available in lyophilized form and is typically reconstituted with Bacteriostatic Water prior to research use.

SKU: 23ba340c9200 Categories: , ,

Description

Tirzepatide is a potent, once-weekly injectable dual agonist (GIP and GLP-1 receptors) that provides significant benefits for weight management and metabolic health. It drives substantial weight loss (up to 20.9%), improves glycemic control, reduces appetite, lowers blood pressure, and helps manage obesity-related conditions like sleep apnea.

 

  • Significant Weight Loss: Clinical trials show that participants on tirzepatide experienced 5% to 20.9% weight reduction, making it one of the most effective medical treatments for weight loss.
  • Enhanced Appetite Control: By acting on GIP and GLP-1 receptors, it slows digestion and boosts feelings of fullness (satiety), which significantly reduces food intake.
  • Improved Glycemic Control: Initially used for type 2 diabetes, it effectively lowers HbA1c levels, improving long-term blood glucose management.
  • Improved Body Composition: Evidence suggests that weight loss from tirzepatide is primarily due to a reduction in fat mass.
  • Cardiovascular and Metabolic Health: It is associated with improvements in lipid profiles and reduced blood pressure, which can decrease cardiovascular risks.
  • Reduction in Chronic Disease Risks: By promoting significant weight loss, it aids in managing obesity-related complications, such as moderating obstructive sleep apnea (OSA) and reducing fat around organs

Questions about this product